ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 274,48
-0,27%
Dow Jones
42 840,26
1,18%
DAX
19 884,75
-0,57%
Brent Oil
72,72
0,00%
Bitcoin
97 583,13
-0,18%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. USOTC

  6. Abattis Bioceuticals Corporation (CE) (ATTBF) Cours

Abattis Bioceuticals Corporation (CE)

Abattis Bioceuticals Corporation (CE) (ATTBF)

USOTC
0,000001
0,00
(0,00%)
Fermé 21 Décembre 10:00PM
Retardé de 15 minutes

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Statistiques et détails clés

Dernier
0,000001
Prix Achat
0,00
Prix Vente
0,00
Volume échangé
7 185
0,000001 Fourchette du Jour 0,000001
0,000001 Plage de 52 semaines 0,000134
Clôture Veille
0,000001
Ouverture
0,000001
Dernière Transaction
7185
@
1.0E-6
Dernière heure de transaction
Volume moyen (3 m)
45 488
Volume financier
US$ 0
VWAP
0,000001

ATTBF Dernières nouvelles

Plus de nouvelles

S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports

S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports PR Newswire NEW YORK, March 25, 2015 NEW YORK, March 25, 2015 /PRNewswire/...

25 Mars 2015
PR Newswire (US)

ANALYST REPORTS ON COMPANIES ANNOUNCING GAME CHANGING DEVELOPMENTS

  Burton, MI - October 02, 2014 - InvestorsHub NewsWire - Anavex Life Sciences Corp. (OTCQB: AVXL) is a clinical-stage biopharmaceutical company engaged in the development of novel drug...

02 Octobre 2014
InvestorsHub NewsWire

OTC Markets Group Welcomes Abattis Bioceuticals to OTCQX®

OTC Markets Group Welcomes Abattis Bioceuticals to OTCQX® PR Newswire NEW YORK, July 11, 2014 NEW YORK, July 11, 2014 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of Open...

11 Juillet 2014
PR Newswire (US)

Industrial Hemp and Medical Marijuana Industry Gather for GreenRush Financial Conference in Vancouver

VANCOUVER,B.C., May 5, 2014 (GLOBE NEWSWIRE) -- A hundred and fifty years ago, Harry Barr's (President and CEO of Next Gen Metals) (CSE:N) (OTC Pink:NXTTF), ancestors began farming in the Ottawa...

05 Mai 2014
GlobeNewswire Inc.

Abattis Provides $10,000 Sponsorship to the American Herbal Pharmacopoeia for Cannabis Monograph Project

Abattis Provides $10,000 Sponsorship to the American Herbal Pharmacopoeia for Cannabis Monograph Project Sponsorship will fund completion of monograph to guide commercial production in Canada PR...

12 Mars 2013
PR Newswire (US)

Abattis Participates In Project On A Whole Plant Therapeutic For Treating Malaria And Other Diseases And Reducing Drug Resist...

Abattis Participates In Project On A Whole Plant Therapeutic For Treating Malaria And Other Diseases And Reducing Drug Resistance PR Newswire VANCOUVER, British Columbia, March 8, 2013 VANCOUVER...

08 Mars 2013
PR Newswire (US)

Abattis Signs LOI With Crudessence Kombucha Inc. To License Infused, Blended Kombucha Tea

Abattis Signs LOI With Crudessence Kombucha Inc. To License Infused, Blended Kombucha Tea PR Newswire VANCOUVER, British Columbia, March 6, 2013 VANCOUVER, British Columbia, March 6, 2013...

06 Mars 2013
PR Newswire (US)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1001.0E-61.0E-61.0E-6323491.0E-6CS
4001.0E-61.0E-61.0E-6805941.0E-6CS
12001.0E-60.00011.0E-6454881.18E-6CS
26001.0E-60.0001341.0E-6343701.15E-6CS
52001.0E-60.0001341.0E-6246941.16E-6CS
156-9.9E-5-990.00010.0011.0E-6246481.228E-5CS
260-0.004199-99.97619047620.00420.0771.0E-63280540.01361CS

ATTBF - Frequently Asked Questions (FAQ)

What is the current Abattis Bioceuticals (CE) share price?
The current share price of Abattis Bioceuticals (CE) is US$ 0,000001
What is the 1 year trading range for Abattis Bioceuticals (CE) share price?
Abattis Bioceuticals (CE) has traded in the range of US$ 0,000001 to US$ 0,000134 during the past year

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
ELIQQElectriq Power Holdings Inc (CE)
US$ 0,10
(99 900,00%)
100
GNTLFGenetic Technologies Ltd (PK)
US$ 1,00
(90 809,09%)
100
VIVEViveve Medical Inc (CE)
US$ 0,0003
(29 900,00%)
7,33k
BTIMBoatim Inc (CE)
US$ 0,0002
(19 900,00%)
799
CLVRClever Leaves Holdings Inc (CE)
US$ 0,0002
(19 900,00%)
592
RAASYCloopen Group Holding Limited (CE)
US$ 0,000001
(-100,00%)
214
EWGFFEat Well Investment Group Inc (CE)
US$ 0,000001
(-100,00%)
47,01k
SOLBFSoLVBL Solutions Inc (CE)
US$ 0,000001
(-99,99%)
10k
HAVLFHavn Life Sciences Inc (CE)
US$ 0,000001
(-99,98%)
4,02k
ENDRFEndor AG (GM)
US$ 0,0001
(-99,98%)
560
HMBLHUMBL Inc (PK)
US$ 0,00095
(5,56%)
344,89M
PHILPHI Group Inc (PK)
US$ 0,0003
(0,00%)
312,21M
PLPLPlandai Biotechnology Inc (PK)
US$ 0,0001
(0,00%)
215,71M
RDARRaadr Inc (PK)
US$ 0,0014
(16,67%)
174,96M
CHNVFChina Youzan Ltd (PK)
US$ 0,0177
(10,63%)
100M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

USOTC
ATTBF
Abattis Bioceuticals (CE)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés